Autologous CIK Cell Immunotherapy in Patients with Renal Cell Carcinoma after Radical Nephrectomy
Objective. To evaluate the efficacy of autologous cytokine-induced killer (CIK) cells in patients with renal cell carcinoma (RCC). Methods. 20 patients diagnosed with TNM stage I or II RCC were randomly divided into two groups, a CIK cell treatment group and a control group. The endpoint was progres...
Main Authors: | Yajing Zhang, Jin Wang, Yao Wang, Xue-Chun Lu, Hui Fan, Yang Liu, Yan Zhang, Kai-Chao Feng, Wen-Ying Zhang, Mei-Xia Chen, Xiaobing Fu, Wei-Dong Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2013/195691 |
Similar Items
-
The efficacy and safety of the combination of axitinib and pembrolizumab‐activated autologous DC‐CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study
by: Meng‐Jia Song, et al.
Published: (2021-01-01) -
Retroperitoneoscopic radical nephrectomy for renal cell carcinoma
by: Narmada P Gupta, et al.
Published: (2002-01-01) -
Adoptive Immunotherapy Strategies with Cytokine-Induced Killer (CIK) Cells in the Treatment of Hematological Malignancies
by: Frederic Carsten Schmeel, et al.
Published: (2014-08-01) -
Comparison of laparoscopy and open radical nephrectomy of renal cell cancer
by: Wang Dong, et al.
Published: (2019-05-01) -
RADICAL NEPHRECTOMY IN THE MANAGEMENT OF LOCALIZED RENAL CELL CARCINOMA
by: Mir Alam Jan, et al.
Published: (2016-02-01)